Literature DB >> 11706309

Urinary cytokines: clinically useful markers of chronic renal disease progression?

W Wong1, A K Singh.   

Abstract

Many factors that drive glomerular and tubulointerstitial fibrogenesis have been identified. These include hemodynamic factors, chemokines, inflammatory mediators, cytokines, and lipids. These strides in knowledge are important in identifying those patients at increased risk of progressive renal disease as well as in developing targets for therapeutic interventions. Identifying 'progressors' is crucial since the distribution of the slope of the glomerular filtration rate of patients with chronic kidney disease is not normal. Some patients appear to progress very rapidly, such as those with diabetes, whereas other patients fail to progress at all. Developing strategies targeted at identifying the fast from the slow progressors is therefore of paramount importance if we are to deploy resources rationally in the management of patients with chronic kidney disease. The use of urinary cytokine markers as predictors of progression of renal disease is reviewed in this paper.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706309     DOI: 10.1097/00041552-200111000-00012

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  2 in total

1.  Role of transforming growth factor-β2 in, and apossible transforming growth factor-β 2 gene polymorphism as a marker of, renal dysfunction in essential hypertension: A study in Turkish patients.

Authors:  Zerrin Bicik; Sevim Gönen; Talat Bahçebasi; Kadriye Reis; Turgay Arinsoy; Sükrü Sindel
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

2.  Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.

Authors:  Pawel P Wolkow; Monika A Niewczas; Bruce Perkins; Linda H Ficociello; Boguslaw Lipinski; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.